Fundz

Fundz Deep Dive

Everything you need to win Michael Hanley — in one platform.

Who to reach, what to say, and why now on Michael Hanley — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Michael Hanley — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Alto Names Michael Hanley As Chief Operating Officer

PUBLIC · ANROMay 21, 2024about 2 years ago

Position

Chief Operating Officer

Company

Alto Neuroscience

Michael Hanley
Mountain ViewBiotechnologyHealth Care

Description

Alto Neuroscience, Inc. announced the addition of Michael Hanley as chief operating officer (COO) to lead new product planning, portfolio strategy, and cross-functional leadership

Company Information

Company

Alto Neuroscience

Location

Mountain View, California, United States

About

Alto Neuroscience is a biopharmaceutical company redefining psychiatry through its Precision Psychiatry Platform™, which leverages individuals’ neurobiology to develop personalized and highly effective medicines that help patients get better faster. By integrating biomarkers such as EEG and wearable data, behavioral patterns, genetics, and other biological factors, Alto uses AI-driven insights to match each patient with the treatment they are most likely to respond to—bringing a new era of precision and effectiveness to mental health care.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Alto Neuroscience's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.